| Is technological change in medicine always worth it? The case of acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 16464904 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We examine Medicare costs and survival gains for acute myocardial infarction (AMI) during 1986-2002. As David Cutler and Mark McClellan did in earlier work, we find that overall gains in post-AMI survival more than justified the increases in costs during this period. Since 1996, however, survival gains have stagnated, while spending has continued to increase. We also consider changes in spending and outcomes at the regional level. Regions experiencing the largest spending gains were not those realizing the greatest improvements in survival. Factors yielding the greatest benefits to health were not the factors that drove up costs, and vice versa. |
| | |
Authors:
|
Jonathan S Skinner; Douglas O Staiger; Elliott S Fisher |
Related Documents
:
|
20832064 - Association of cd40 ligand levels in the culprit coronary arteries with subsequent prog... 19938054 - Oral l-arginine supplementation in acute myocardial infarction therapy: a meta-analysis... 8556774 - Acute myocardial infarction in zimbabwe: the changing scene of coronary artery disease. 9084994 - Validity of diagnoses of major coronary events in national registers of hospital diagno... 6144264 - Role of beta-adrenoreceptor antagonism in the prevention of reperfusion ventricular arr... 16375634 - Chagas cardiomyopathy and ischemic stroke. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2006-02-07 |
Journal Detail:
|
Title: Health affairs (Project Hope) Volume: 25 ISSN: 1544-5208 ISO Abbreviation: Health Aff (Millwood) Publication Date: 2006 Mar-Apr |
Date Detail:
|
Created Date: 2006-03-08 Completed Date: 2006-10-10 Revised Date: 2013-04-24 |
Medline Journal Info:
|
Nlm Unique ID: 8303128 Medline TA: Health Aff (Millwood) Country: United States |
Other Details:
|
Languages: eng Pagination: w34-47 Citation Subset: IM |
Affiliation:
|
Dartmouth Medical College. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adrenergic beta-Antagonists / therapeutic use Aged Biomedical Technology / economics* Cardiac Catheterization Cost-Benefit Analysis Female Humans Male Medicare / economics* Myocardial Infarction / economics*, mortality*, therapy Proportional Hazards Models Survival Analysis Technology Assessment, Biomedical / economics* Treatment Outcome United States |
| Grant Support | |
ID/Acronym/Agency:
|
P01 AG019783/AG/NIA NIH HHS; P01 AG019783-06/AG/NIA NIH HHS; P01-AG19783/AG/NIA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists |
| Comments/Corrections | |
Comment In:
|
Health Aff (Millwood). 2006 Mar-Apr;25(2):w48-50
[PMID:
16464902
]
Health Aff (Millwood). 2006 Mar-Apr;25(2):w51-3 [PMID: 16464903 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: To use technology better.
Next Document: Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel ...